CROSSROADS STRATEGIES, LLC for BRISTOL-MYERS SQUIBB
What was lobbied
4 issue areas, each in the filer's own words, with who lobbied on it and where.
Budget/Appropriations BUD
H.R.5961/S.2976, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2019; Food and Drug Administration (FDA) related issues.
| Lobbyist | Covered position, as disclosed |
|---|---|
| KATHERINE DAPPER | — |
| JASON GLEASON | — |
| SHAY MICHAEL HANCOCK | — |
| MATHEW LAPINSKI | — |
| HUNTER MOORHEAD | — |
| JASON BENJAMIN VAN PELT | — |
Taxation/Internal Revenue Code TAX
Implementation of H.R.1, Tax Cuts and Jobs Act (P.L.115-97). H.R.88, Retirement, Savings, and Other Tax Relief Act of 2018 and Taxpayer First Act of 2018.
| Lobbyist | Covered position, as disclosed |
|---|---|
| KATHERINE DAPPER | — |
| JASON GLEASON | — |
| SHAY MICHAEL HANCOCK | — |
| MATHEW LAPINSKI | — |
| HUNTER MOORHEAD | — |
| JASON BENJAMIN VAN PELT | — |
Health Issues HCR
Issues related to health care, the Food and Drug Administration (FDA), oncology coverage, 340B Program, truthful non-misleading industry communications, drug pricing, and drug importation policy. Implementation of 21st Century Cures Act (P.L.114-255).
| Lobbyist | Covered position, as disclosed |
|---|---|
| KATHERINE DAPPER | — |
| JASON GLEASON | — |
| SHAY MICHAEL HANCOCK | — |
| MATHEW LAPINSKI | — |
| HUNTER MOORHEAD | — |
| JASON BENJAMIN VAN PELT | — |
Medicare/Medicaid MMM
General issues related to Medicare and Medicaid, such as: Part D Medicare Program (including Coverage Gap and other offsets) and Medicare Part B reimbursement. Proposed Part B IPI Demonstration Project.
| Lobbyist | Covered position, as disclosed |
|---|---|
| KATHERINE DAPPER | — |
| JASON GLEASON | — |
| SHAY MICHAEL HANCOCK | — |
| MATHEW LAPINSKI | — |
| HUNTER MOORHEAD | — |
| JASON BENJAMIN VAN PELT | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.